BVS Q4 2022 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$593M

Q4 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$126M-3.5% YoY

Gross Profit

$74M59.0% margin

Operating Income

-$25M-20.2% margin

Net Income

-$32M-25.4% margin

EPS (Diluted)

$-0.52

QoQ Revenue Growth

-2.2%

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

$2M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$960M

Stockholders' Equity

$325M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$126M	$130M	-3.5%
Gross Profit	$74M	$88M	-15.5%
Operating Income	-$25M	-$3M	-707.5%
Net Income	-$32M	-$364,000	-8672.0%

Geographic Segments

UNITED STATES

$35M89%

Non-US

$4M11%